Eton Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Eton Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Eton Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $10K, a 54.5% decline year-over-year.
  • Eton Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $88K, unchanged from 2022.
  • Eton Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $88K, a 6.02% increase from 2021.
  • Eton Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $83K, a 36.6% decline from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $10K -$12K -54.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $22K +$2K +10% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $20K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2020 $32K -$1K -3.03% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-14
Q1 2019 $33K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.